By Tom McParland | February 5, 2019
A Delaware judge has blocked an attempt by a contingent of leading pharmaceutical manufacturers and distributors to escape a civil lawsuit by the state, which seeks to hold the companies liable for their alleged role in the ongoing opioid epidemic.
By Tom McParland | February 4, 2019
A Delaware judge Monday blocked an attempt by a contingent of leading pharmaceutical manufacturers and distributors to escape a civil lawsuit by the state seeking to hold the companies liable for their alleged role in the state's opioid epidemic.
By Tom McParland | June 12, 2018
The Delaware Supreme Court on Monday upheld a $71 million award against a Pennsylvania-based pharmaceutical company that failed to live up to its obligation to market a drug used to treat exposure to certain types of chemotherapy.
Delaware Business Court Insider | News
By Tom McParland | May 15, 2018
GlaxoSmithKline is appealing a Delaware federal district judge's ruling that wiped out a $235 million verdict against Teva Pharmaceuticals for allegedly infringing a patent for the hypertension drug Coreg.
Delaware Business Court Insider | News
By Tom McParland | March 29, 2018
A Delaware federal judge on Wednesday wiped out a $235 million verdict against Teva Pharmaceuticals for supposedly infringing a GlaxoSmithKline plc patent for the hypertension drug Coreg.
Delaware Business Court Insider | News
By Tom McParland | March 13, 2018
A Delaware patent infringement case has erupted into an antitrust dispute, after an India-based generic drugmaker accused Mylan Pharmaceuticals of using its lawsuit to stifle competition for its topical foam acne treatment.
By Tom McParland | January 30, 2018
Three pharmaceutical companies on Tuesday added another patent to an infringement suit against Sandoz Inc., as it tries to prevent a contingent of drugmakers from bringing generic versions of the gastrointestinal drug Linzess to market.
By Tom McParland | January 19, 2018
Delaware Attorney General Matt Denn on Friday sued a contingent of leading pharmaceutical manufacturers and distributors in an effort to hold them accountable for their alleged role in the state's opioid epidemic.
By Scott Graham | November 1, 2017
In a win for Goodwin Procter, a unanimous panel ruled Wednesday that a patent covering Bayer's Staxyn is obvious in light of numerous previous patent applications and medical journal articles. The decision reverses U.S. District Judge Gregory Sleet of Delaware.
By Tom McParland | October 31, 2017
Pfizer Inc. on Monday accused Florida-based generic drugmaker Breckenridge Pharmaceutical Inc. of infringing four patents for Xeljanz, as the company continues its campaign to protect the rheumatoid arthritis drug from generic competition.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS